ACTB and hepatocellular carcinoma: Investigation of clustering β-actin resource in HCC shows that mutant β-actins are responsible for 12–26% of patients, whereas mutations in Wnt/β-actin pathway contribute 8–13% cases, both of which predominantly occur in HCV-infected population (149).